γ-Glutamylamines and neurodegenerative diseases.

Titleγ-Glutamylamines and neurodegenerative diseases.
Publication TypeJournal Article
Year of Publication2013
AuthorsJeitner TM, Battaile K, Cooper AJL
JournalAmino Acids
Volume44
Issue1
Pagination129-42
Date Published2013 Jan
ISSN1438-2199
KeywordsAmines, Animals, Dipeptides, gamma-Glutamylcyclotransferase, Glutamine, Humans, Lysine, Neurodegenerative Diseases, Protein Processing, Post-Translational, Transglutaminases
Abstract

Transglutaminases catalyze the formation of γ-glutamylamines utilizing glutamyl residues and amine-bearing compounds such as lysyl residues and polyamines. These γ-glutamylamines can be released from proteins by proteases in an intact form. The free γ-glutamylamines can be catabolized to 5-oxo-L-proline and the free amine by γ-glutamylamine cyclotransferase. Free γ-glutamylamines, however, accumulate in the CSF and affected areas of Huntington Disease brain. This observation suggests transglutaminase-derived γ-glutamylamines may play a more significant role in neurodegeneration than previously thought. The following monograph reviews the metabolism of γ-glutamylamines and examines the possibility that these species contribute to neurodegeneration.

DOI10.1007/s00726-011-1209-3
Alternate JournalAmino Acids
PubMed ID22407484
PubMed Central IDPMC3491119
Grant ListP01 AG014930 / AG / NIA NIH HHS / United States
2P01 AG14930 / AG / NIA NIH HHS / United States
Related Institute: 
Molecular Imaging Innovations Institute (MI3)

Weill Cornell Medicine
Department of Radiology
525 East 68th Street New York, NY 10065